Article

VIDEO: Sarah Thomas Speaks About Quality Improvement Strategies for Health Insurance Exchanges

Sarah Thomas, Vice President, Public Policy and Communications, NCQA, states that there are 3 significant pieces of quality improvement strategies for health insurance exchanges.

Sarah Thomas, Vice President, Public Policy and Communications, NCQA, states that there are 3 significant pieces of quality improvement strategies for health insurance exchanges.

First, there is the process for delivering quality measures to consumers in order for them to choose a plan. Second, setting a set of provisions around health plans while working on strategies to improve value (eg, using benefit design in ways to get better value and setting up a competitive environment for health plans to compete for quality that provides the best care with the lowest premium). Finally, the third quality improvement strategy is deciding who is able to be in the health insurance exchanges. These decisions are made with accreditation and qualification criteria.

This video interview was performed on June 20, 2012, at the America's Health Insurance Plans Institute 2012 in Salt Lake City, UT.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Kimberly Westrich, MA, chief strategy officer, NPC
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo